Ornithine carbamoyltransferase deficiency: genes and variants

Explore variant evidence for Ornithine carbamoyltransferase deficiency across 1 analyzed protein (OTC). Linked ClinVar records include 135 pathogenic or likely pathogenic variants, 106 variants of uncertain significance and 35 with conflicting classifications.

Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.

Data updated 2026-10-15. Automated aggregation, not a clinical review date.

Download variant evidence (CSV)

Genes linked to Ornithine carbamoyltransferase deficiency

ClinVar pathogenic and likely pathogenic variants linked to Ornithine carbamoyltransferase deficiency

VariantPositionProtein partClinical label
OTC R26Q26Pathogenic / likely pathogenic (★★★★)
OTC P225L225Pathogenic / likely pathogenic (★★)
OTC R277Q277Pathogenic / likely pathogenic (★★)
OTC R277W277Pathogenic / likely pathogenic (★★)
OTC R40C40Pathogenic / likely pathogenic (★★)
OTC R141Q141Pathogenic / likely pathogenic (★★)
OTC P169L169Pathogenic / likely pathogenic (★★)
OTC G188R188Pathogenic / likely pathogenic (★★)
OTC W193R193Pathogenic / likely pathogenic (★★)
OTC G195R195Pathogenic / likely pathogenic (★★)
OTC D196N196Pathogenic / likely pathogenic (★★)
OTC M205T205Pathogenic / likely pathogenic (★★)
OTC M206R206Pathogenic / likely pathogenic (★★)
OTC M206K206Pathogenic / likely pathogenic (★★)
OTC K210E210Pathogenic / likely pathogenic (★★)
OTC P225S225Pathogenic / likely pathogenic (★★)
OTC R40L40Pathogenic / likely pathogenic (★★)
OTC R40H40Pathogenic / likely pathogenic (★★)
OTC R129H129Pathogenic / likely pathogenic (★★)
OTC M206I206Pathogenic / likely pathogenic (★★)
OTC S207R207Pathogenic / likely pathogenic (★★)
OTC M1I1Pathogenic / likely pathogenic (★★)
OTC K80E80Pathogenic / likely pathogenic (★★)
OTC S81P81Pathogenic / likely pathogenic (★★)
OTC L139S139Pathogenic / likely pathogenic (★★)
OTC P158L158Pathogenic / likely pathogenic (★★)
OTC I159M159Pathogenic / likely pathogenic (★★)
OTC T178M178Pathogenic / likely pathogenic (★★)
OTC G197R197Pathogenic / likely pathogenic (★★)
OTC N199S199Pathogenic / likely pathogenic (★★)
OTC A209V209Pathogenic / likely pathogenic (★★)
OTC A233V233Pathogenic / likely pathogenic (★★)
OTC S340F340Pathogenic / likely pathogenic (★★)
OTC I53T53Pathogenic / likely pathogenic (★★)
OTC R92Q92Pathogenic / likely pathogenic (★★)
OTC E122G122Pathogenic / likely pathogenic (★★)
OTC N161S161Pathogenic / likely pathogenic (★★)
OTC Y183C183Pathogenic / likely pathogenic (★★)
OTC D263G263Pathogenic / likely pathogenic (★★)
OTC L304F304Pathogenic / likely pathogenic (★★)
OTC R330G330Pathogenic / likely pathogenic (★★)
OTC K221N221Pathogenic / likely pathogenic (★★)
OTC E239D239Pathogenic / likely pathogenic (★★)
OTC R141P141Pathogenic / likely pathogenic (★)
OTC P225Q225Pathogenic / likely pathogenic (★)
OTC G39V39Pathogenic / likely pathogenic (★)
OTC L45R45Pathogenic / likely pathogenic (★)
OTC I160F160Pathogenic / likely pathogenic (★)
OTC G162R162Pathogenic / likely pathogenic (★)
OTC G162V162Pathogenic / likely pathogenic (★)
OTC L163Q163Pathogenic / likely pathogenic (★)
OTC H168Y168Pathogenic / likely pathogenic (★)
OTC H168R168Pathogenic / likely pathogenic (★)
OTC P169S169Pathogenic / likely pathogenic (★)
OTC P169A169Pathogenic / likely pathogenic (★)
OTC Q180P180Pathogenic / likely pathogenic (★)
OTC Q180H180Pathogenic / likely pathogenic (★)
OTC G188V188Pathogenic / likely pathogenic (★)
OTC W193C193Pathogenic / likely pathogenic (★)
OTC D196Y196Pathogenic / likely pathogenic (★)

Showing 60 of 135.

Uncertain variants prioritized for review in Ornithine carbamoyltransferase deficiency

VariantPositionProtein partClinical labelEvidence
OTC M268I268Conflicting reports (★)+7: M268K at the same position is pathogenic; seen in 8.9e-06 of gnomAD DNA copies; REVEL 0.944
OTC G39D39Conflicting reports (★)+7: 6 other pathogenic changes within 3 positions; G39V at the same position is pathogenic; seen in 0 of gnomAD DNA copies; REVEL 0.834
OTC A140V140Conflicting reports (★)+7: 4 other pathogenic changes within 3 positions; A140P at the same position is pathogenic; seen in 0 of gnomAD DNA copies; REVEL 0.823
OTC D126E126Conflicting reports (★)+7: 2 other pathogenic changes within 3 positions; D126N at the same position is pathogenic; seen in 0 of gnomAD DNA copies; REVEL 0.905
OTC T343I343Conflicting reports (★)+7: 4 other pathogenic changes within 3 positions; T343R at the same position is pathogenic; seen in 9.2e-07 of gnomAD DNA copies; REVEL 0.780
OTC G162A162Conflicting reports (★)+7: 9 other pathogenic changes within 3 positions; G162R at the same position is pathogenic; seen in 9.2e-07 of gnomAD DNA copies; REVEL 0.812
OTC D126G126Uncertain (★)+7: 2 other pathogenic changes within 3 positions; D126N at the same position is pathogenic; seen in 0 of gnomAD DNA copies; REVEL 0.980
OTC S164P164Uncertain (★)+7: 6 other pathogenic changes within 3 positions; S164L at the same position is pathogenic; seen in 0 of gnomAD DNA copies; REVEL 0.966
OTC S203F203Conflicting reports (★)+6: 11 other pathogenic changes within 3 positions; S203P at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 1.00
OTC M205R205Uncertain (★)+6: 11 other pathogenic changes within 3 positions; M205K at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.97
OTC P158R158Uncertain (★)+6: 5 other pathogenic changes within 3 positions; P158L at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.91
OTC D175N175Uncertain (★)+6: 3 other pathogenic changes within 3 positions; D175Y at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.95
OTC P347R347Uncertain (★)+6: 4 other pathogenic changes within 3 positions; P347T at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.74
OTC R129C129Uncertain (★★)+6: 3 other pathogenic changes within 3 positions; R129H at the same position is pathogenic; REVEL 0.908
OTC A209G209Uncertain (★★)+6: 10 other pathogenic changes within 3 positions; A209E at the same position is pathogenic; REVEL 0.836
OTC S81F81Uncertain (★★)+6: 3 other pathogenic changes within 3 positions; S81P at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.70

Which prediction tools work for Ornithine carbamoyltransferase deficiency

Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.

Diseases related to Ornithine carbamoyltransferase deficiency

Frequently asked questions

Which genes have records linked to Ornithine carbamoyltransferase deficiency?

This view contains 1 analyzed proteins: OTC. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.

What do the clinical classifications mean?

Linked records include 135 pathogenic or likely pathogenic variants, 106 variants of uncertain significance and 35 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.

Does the evidence score change a VUS classification?

No. 16 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.

Can I download the variant evidence?

Download the CSV for all 312 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.

About this data

Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.

Download every variant as CSV · Browse all diseases · Methods · About the Center